Article | Peptides

Last update: February 7, 2026 | Author: Siri Napan, MD

GHK‑Cu (Glycyl‑L‑Histidyl‑L‑Lysine Copper) is a naturally occurring copper‑binding tripeptide found in human plasma and extracellular matrix. It plays an important role in skin repair, connective tissue remodeling, and inflammatory regulation, and has been widely studied in dermatologic and regenerative medicine.

GHK‑Cu levels decline with age, which has driven interest in its therapeutic use for skin rejuvenation, wound healing, and tissue recovery.

What Is GHK‑Cu?

GHK‑Cu is classified as a carrier peptide, binding copper ions and delivering them to tissues where copper‑dependent enzymes are required for repair and remodeling. It influences multiple cellular pathways involved in:

• Fibroblast activation
• Collagen and elastin turnover
• Angiogenesis or new blood vessel formation
• Antioxidant and anti‑inflammatory signaling

GHK‑Cu has been most extensively studied in dermatology and wound healing, with emerging interest in broader regenerative applications 1 2.

Potential Benefits

Published experimental and clinical dermatology data suggest GHK‑Cu may support:

• Improved wound healing and scar modulation
• Enhanced collagen and elastin synthesis
• Improved skin firmness and elasticity
• Reduction in fine lines and photodamage
• Anti‑inflammatory and antioxidant effects
• Support of hair follicle and scalp health

At the molecular level, GHK‑Cu regulates matrix metalloproteinases, promotes angiogenesis, and supports extracellular matrix remodeling 2 3.

Clinical Use and Administration

Injectable GHK‑Cu (Subcutaneous)

GHK‑Cu is typically administered subcutaneously in regenerative and aesthetic medicine settings.

Commonly used clinical ranges (empirical):

• • 1–2 mg per injection
  • Frequency: 1–3 times per week
  • Typical course: 4–8 weeks

Formal dosing standards have not been established, and protocols are based on extrapolation from dermatologic and experimental data rather than large human trials 1.

Topical GHK‑Cu

Topical application remains the most studied and widely used route, particularly in dermatology.

Common topical concentrations:

• • 0.05%–0.5% GHK‑Cu in creams, serums, or gels

Formulation stability and skin penetration are critical for effectiveness 4, 5.

Safety and Evidence Considerations

GHK‑Cu is generally well tolerated, particularly when used topically or at conservative injectable doses. Because it is endogenous to the human body, adverse effects are uncommon when appropriately prepared and administered.

However, current orthopedic and regenerative reviews emphasize that:

• • Human clinical data outside dermatology remain limited
  • Optimal dosing, frequency, and duration are not yet standardized
  • Use should be individualized and evidence‑informed rather than protocol‑driven 1, 2

Key Takeaway

GHK‑Cu is a well‑studied regenerative peptide in dermatology with demonstrated roles in skin repair, collagen remodeling, and inflammation control. While injectable use is expanding in regenerative medicine, current evidence supports a measured, conservative approach, with topical therapy remaining the most established modality.

Important Note: This guide is for educational purposes only and should not replace professional medical advice. Always consult with your healthcare provider before starting or stopping any medication. Individual results vary, and what works for one person may not work for another.

References

1. Injectable peptide therapy: a primer for orthopaedic and sports medicine physicians. The American Journal of Sports Medicine, 2026
2. Therapeutic peptides in orthopaedics: applications, challenges, and future directions. Journal of the American Academy of Orthopaedic Surgeons: Global Research & Reviews, 2026
3. Dimeric copper peptide incorporated hydrogel for promoting diabetic wound healing. Nature Communications, 2025
4. Cosmeceutical peptides. Dermatologic Surgery, 2005
5. Cosmeceutical peptides. Dermatologic Therapy, 2007